Ohgi M
No ORCID on file
· 1 paper in corpus
other
2026
BACKGROUND: Relugolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, represents a potentially effective and less invasive therapeutic approach for retained products of conception (RPOC). However, its impact on subsequent pregnan…